Oral Decitabine/Cedazuridine Vs Intravenous Decitabine for Acute Myeloid Leukemia: Final Results of a Randomized, Crossover, Registration-Enabling, Pharmacokinetics Study

被引：0

作者：

Geissler, Klaus ^{[1
,2
]}

Koristek, Zdenek ^{[3
]}

Del Castillo, Teresa Bernal ^{[4
]}

Novak, Jan ^{[5
,6
]}

Macias, Gabriela Rodriguez ^{[7
]}

Metzelder, Stephan ^{[8
]}

Illes, Arpad ^{[9
]}

Nagy, Agnes ^{[10
]}

Mayer, Jiri ^{[11
,12
]}

Arnan Sangerman, Montserrat ^{[13
]}

Keating, Mary-Margaret ^{[14
]}

Krauter, Juergen ^{[15
]}

Lunghi, Monia ^{[16
]}

Fracchiolla, Nicola ^{[17
]}

Platzbecker, Uwe ^{[18
]}

Santini, Valeria ^{[19
]}

Chan, Danna ^{[20
]}

Mirakhur, Beloo ^{[20
]}

Sano, Yuri ^{[20
]}

Oganesian, Aram ^{[20
]}

Keer, Harold N. ^{[20
]}

Luebbert, Michael ^{[21
]}

机构：

[1] Clin Hietzing, Vienna, Austria

[2] Sigmund Freud Univ, Vienna, Austria

[3] Univ Hosp Ostrava, Ostrava, Czech Republic

[4] Hosp Univ Cent Asturias, ISPA, IUOPA, Oviedo, Spain

[5] Charles Univ Prague, Prague, Czech Republic

[6] Fac Hosp Kralovske Vinohrady, Prague, Czech Republic

[7] Hosp Univ Gregorio Maranon, Madrid, Spain

[8] Philipps Univ Marburg, Marburg, Germany

[9] Univ Debrecen, Dept Hematol, Fac Med, Debrecen, Hungary

[10] Univ Pecs, Pecs, Hungary

[11] Masaryk Univ, Brno, Czech Republic

[12] Univ Hosp Brno, Brno, Czech Republic

[13] Univ Barcelona, Dept Hematol, Inst Catala Oncol, Hosp Duran & Reynals,Inst Invest Biomed Bellvitge, Barcelona, Spain

[14] Queen Elizabeth II QEII Hlth Sci Ctr, Halifax, NS, Canada

[15] Stadt Klinikum Braunschweig, Dept Hematol & Oncol, Braunschweig, Germany

[16] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy

[17] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Hematol Unit, Milan, Italy

[18] Univ Hosp Leipzig, Dept Hematol, Leipzig, Germany

[19] Univ Florence, DMSC, AOU Careggi, MDS Unit, Florence, Italy

[20] Astex Pharmaceut Inc, Pleasanton, CA USA

[21] Univ Med Ctr Freiburg, Freiburg, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-173092

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[41] Randomized study of decitabine versus conventional care (CC) in patients (pts) with intermediate- and high-risk acute myeloid leukemia (AML) in first or subsequent complete remission (CR).
Kashani, F. Ravandi
Jorgensen, J.
Fader, S.
Issa, J.
Autry, J.
Garcia-Manero, G.
Borthakur, G.
Huang, X.
Cortes, J. E.
Kantarjian, H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[42] Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Agrawal, Vaibhav
Croslin, Cindy
Beltran, Asuscena L.
Zhang, Jianying
Palmer, Joycelynne
Quy Huynh-Tran
Hernandez, Rochelle
Thomas, Sandra
Robbins, Marjorie
Aribi, Ahmed
Ali, Haris
Stein, Anthony S.
Budde, Elizabeth L.
Al Malki, Monzr M.
Marcucci, Guido
BLOOD, 2022, 140 : 6235 - 6236
[43] Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor- or intermediate-risk cytogenetics
Jiří Mayer
Christopher Arthur
Jacques Delaunay
Grzegorz Mazur
Xavier G Thomas
Agnieszka Wierzbowska
Farhad Ravandi
Erhan Berrak
Mark Jones
Yuhan Li
Hagop M Kantarjian
BMC Cancer, 14
[44] Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
Williams, Casey B.
Kambhampati, Suman
Ganguly, Siddhartha
Aljitawi, Omar S.
Reyes, Ruben
Fleming, Allan
Bhalla, Kapil N.
Abhyankar, Sunil
McGuirk, Joseph
BLOOD, 2011, 118 (21) : 1542 - 1542
[45] Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics
Mayer, Jiri
Arthur, Christopher
Delaunay, Jacques
Mazur, Grzegorz
Thomas, Xavier G.
Wierzbowska, Agnieszka
Ravandi, Farhad
Berrak, Erhan
Jones, Mark
Li, Yuhan
Kantarjian, Hagop M.
BMC CANCER, 2014, 14
[46] Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
Palmieri, Raffaele
Buckley, Sarah A.
Othus, Megan
Halpern, Anna B.
Percival, Mary-Elizabeth M.
Scott, Bart L.
Hendrie, Paul C.
Becker, Pamela S.
Oehler, Vivian G.
Estey, Elihu H.
Walter, Roland B.
LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1728 - 1731
[47] CASCADE: A phase 3, randomized, double-blind study of vadastuximab talirine (33A) versus placebo in combination with azacitidine or decitabine in the treatment of older patients with newly diagnosed acute myeloid leukemia (AML).
Wang, Eunice S.
Ades, Lionel
Fathi, Amir Tahmasb
Kreuzer, Karl A.
O'Meara, Megan Marie
Liang, Shang-Ying
Ravandi, Farhad
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[48] Experience with a therapeutic platelet transfusion strategy in patients with acute myeloid leukemia: final results of a randomized multicenter study comparing a prophylactic with a therapeutic transfusion strategy
Wandt, H.
Schaefer-Eckart, K.
Pilz, B.
Thalheimer, M.
Ho, A.
Schaich, M.
Kaufmann, M.
Aulitzky, W.
Haenel, M.
Herbst, R.
Doelken, G.
Klenner, A.
Freund, M.
Junghanss, C.
Ehninger, G.
ONKOLOGIE, 2010, 33 : 6 - 6
[49] Low Dose Decitabine Versus Best Supportive Care in Elderly Patients with Intermediate or High Risk MDS Not Eligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study (06011) of the EORTC Leukemia and German MDS Study Groups
Wijermans, Pierre
Suciu, Stefan
Baila, Liliana
Platzbecker, Uwe
Giagounidis, Aristoteles
Selleslag, Dominik
Labar, Boris
Salih, Helmut
Beeldens, Filip
Muus, Petra
de Witte, Theo
Luebbert, Michael
BLOOD, 2008, 112 (11) : 90 - 90
[50] QUIZARTINIB (AC220) IN PATIENTS WITH FLT3-ITD(+) RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A RANDOMIZED PHASE 2 STUDY
Russell, N.
Tallman, M. S.
Goldberg, S.
Perl, A. E.
Marie, J. P.
Martinelli, G.
Larson, R. A.
Schiller, G.
Trone, D.
Gammon, G.
Levis, M.
Cortes, J. E.
HAEMATOLOGICA, 2014, 99 : 36 - 36

← 1 2 3 4 5 →